Dermal Bright is a pharmaceutical company dedicated to advancing the treatment of chronic skin conditions. We are currently developing two specialized product lines:
A systemically delivered small molecule therapy designed to modulate the biological pathways involved in dermatologic disease. DB-01 aims to address underlying causes at the molecular level to provide durable, whole-body treatment effects.
A topical formulation engineered to deliver active agents directly to affected skin layers. DB-02 is designed to reduce inflammation, restore skin balance, and promote healthy skin appearance through localized, targeted action.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.